companydata.dkGXP PHARMAID ApS: Financial statements 2023
CVR: 29615861
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,192,153 and a net result of DKK 513,163 compared with DKK -324,771 the year before. That is an increase of 240.9% compared with the year before. Equity amounted to DKK 879,679. The solvency ratio was 52.3%. The company had 1 employee in the financial year.
- Gross Profit
- 1,192,153 kr.
- Profit/Loss
- 513,163 kr.
- Equity
- 879,679 kr.
- Total Assets
- 1,682,444 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.2 mio. | 513 t. | 880 t. | 1 |
| 2022 | - | 350 t. | -325 t. | 367 t. | 1 |
| 2021 | - | 363 t. | -504 t. | 691 t. | 2 |
| 2020 | - | 2.8 mio. | 960 t. | 1.7 mio. | 3 |
| 2019 | - | 763 t. | -169 t. | 735 t. | 1 |
Events in 2023
GXP PHARMAID ApS has published its annual report for 2022. Gross profit came to DKK 349,682, and the net result was DKK -324,771.
As of June 15, 2023, BAKER TILLY DENMARK GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of GXP PHARMAID ApS.
As of June 15, 2023, EMIT P/S has stepped down as auditor of GXP PHARMAID ApS.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 2 employees. In 2024, the company reported a gross profit of DKK 1,340,825 and a net result of DKK 216,532 compared with DKK 513,163 the year before. Equity amounted to DKK 1,096,211.